CA 007 500 mg/2000 mg Injection is used to treat severe bacterial infections. It is primarily used in the treatment of lower respiratory tract infections (LRTIs), such as hospital-acquired pneumonia (which occurs 48 hours after hospital admission) and community-acquired pneumonia (which occurs outside of a hospital). Also, it is used to treat febrile neutropenia. Bacterial infections occur when harmful bacteria multiply either inside or on the body. LRTIs are infections of the airways and lungs. Febrile neutropenia is a condition characterized by a low white blood cell count accompanied by fever.

CA 007 500 mg/2000 mg Injection is a combination of two medicines: Cefepime (a cephalosporin antibiotic) and Amikacin (an aminoglycoside antibiotic). Cefepime works by preventing the formation of bacterial cell walls, while Amikacin works by inhibiting the production of bacterial proteins, which are necessary for the survival of the bacteria. Together, these medicines help treat and prevent the spread of bacterial infections.

In some cases, CA 007 500 mg/2000 mg Injection may cause common side effects such as nausea, vomiting, diarrhoea, and pain or inflammation at the injection site. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to consult your doctor if these side effects persist.

Before receiving CA 007 500 mg/2000 mg Injection, inform your doctor if you are allergic to any of its ingredients and to penicillins or other beta-lactam antibiotics. Also, tell your doctor about any other medications you are taking and any existing health conditions to rule out any potential side effects or interactions. Please consult your doctor if you are pregnant or breastfeeding before receiving CA 007 500 mg/2000 mg Injection, as it may harm the baby. You may feel dizzy after receiving CA 007 500 mg/2000 mg Injection, so avoid driving until fully alert. Always complete the entire prescribed course of treatment and do not stop abruptly to prevent the infection from returning or becoming resistant.

CA 007 500 mg/2000 mg Injection is a combination of antibiotic medications used to treat severe bacterial infections. It is primarily used in the treatment of lower respiratory tract infections (LRTIs), such as hospital-acquired (occurs 48 hours or more after hospital admission) and community-acquired (occurs outside of a hospital) pneumonia (lung infection). It is also used to treat febrile neutropenia (low white blood cell count with fever). Additionally, CA 007 500 mg/2000 mg Injection is used to treat skin infections caused by drug-resistant bacteria, bone and joint infections, complicated urinary tract infections, stomach infections, abscesses (painful buildup of pus in body tissue or organs), acute bronchitis (inflammation of the breathing tubes), surgical patients with diabetes, traumatic injuries, and sepsis. CA 007 500 mg/2000 mg Injection contains Cefepime and Amikacin. Cefepime works by preventing the formation of bacterial cell walls, while Amikacin inhibits the production of bacterial proteins. Together, these medicines help kill and prevent the spread of infection-causing bacteria.

Before receiving CA 007 500 mg/2000 mg Injection, inform your doctor if you are allergic to any of its ingredients, penicillins or other beta-lactam antibiotics. Also, inform your doctor about any other medicines you are taking and your health condition to rule out any unpleasant side effects or interactions. Consult your doctor if you are pregnant or breastfeeding before receiving this medication. CA 007 500 mg/2000 mg Injection is safe for children if prescribed by a doctor; the dose and duration may vary depending on the child’s weight and the severity of the infection. You may feel dizzy after receiving CA 007 500 mg/2000 mg Injection, so avoid driving until fully alert. CA 007 500 mg/2000 mg Injection should be used cautiously in patients with neuromuscular disorders, such as Parkinson's disease and myasthenia gravis, as it may worsen muscle weakness. CA 007 500 mg/2000 mg Injection should also be used cautiously in elderly patients with kidney problems. Always complete the entire prescribed course of treatment and do not stop abruptly to prevent the infection from returning or becoming resistant.